Prosecution Insights
Last updated: April 19, 2026

Progeneer Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18040318 MRNA VACCINE COMPRISING ADJUVANT CAPABLE OF KINETIC CONTROL ALLEN, SARAH ELIZABETH 1637 Non-Final OA Feb 02, 2023
18040323 CONJUGATE OF FUNCTIONAL DRUG AND TOLL-LIKE RECEPTOR 7 OR 8 AGONIST OF WHICH ACTIVE SITE IS TEMPORARILY INACTIVATED AND USE THEREOF NESTOR, DONNA MICHELLE 1627 Final Rejection Feb 02, 2023
17909066 LIVE-PATHOGEN-MIMETIC NANOPARTICLES BASED ON PATHOGEN CELL WALL SKELETON, AND PRODUCTION METHOD THEREOF CARTER, SANDRA DILLAHUNT 1674 Final Rejection Sep 02, 2022

Managing Progeneer Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month